Metermine is a medication for weight loss, which is available on Australian market.

This weight loss medication is better known as Phentermine in many other countries of the world. Metermine is usually included as a short-term supplementary means into non-drug therapy of obesity. The anti-obesity drug Metermine several times enhances the effectiveness of traditional weight loss methods (diet therapy and physical activity).

Because Phentermine is an amphetamine derivative, its therapeutic action is based on stimulation of the brain and central nervous system.

Impulses are sent to hypothalamus, when patient feels hungry. Metermine captures these impulses and blocks them up so that person ceases feeling hungry. Thus, people need a minimal amount of food to feel full during anti-obesity therapy with Metermine.

However, to maintain the vital activity, people need energy.

The body gets the energy from accumulated fat deposits during the use of Metermine weight loss tablets. Thus, during the anti-obesity therapy by means of Metermine, person receives less energy than he consumes throughout a day. Eventually, a negative energy balance occurs in the body, providing fat burn.

To increase the fat burn rate during the therapy with anti-obesity drug Metermine, it is recommended to enhance physical activity.

  • While person is making exercises, the amount of fat decreases faster than usually, which helps to lose weight much quicker. Moreover, Metermine maintains weight, obtained because of Metermine therapy.

Compliance with a balanced diet and regular physical activity not just helps to save weight, achieved with Metermine diet pills, but also leads to a further weight loss. Metermine weight loss drug is prescribed for overweight patients, whose BMI is over 30, or whose BMI is over 25 with obesity-related diseases (hypertension, diabetes mellitus or dyslipidemia).

Anorexigenic drug Metermine is designed for obesity treatment in adults and adolescents over 12 years old. The anti-obesity drug Metermine is contraindicated for use, if obesity is accompanied by serious cardiovascular diseases (uncontrolled hypertension, arrhythmia, severe heart failure or stroke). Metermine is not prescribed for patients with history of drug or alcohol addiction.

It is recommended to tell the doctor about all the diseases you had, before using Metermine. Because Metermine works in the CNS, it can interact with some medications. Therefore, before adding Metermine to a combination therapy with any of the drugs, patients should consult a medical specialist.